Literature DB >> 7329999

Malignant tumours in dialysis patients: a nationwide survey.

K Ota, N Yamashita, T Suzuki, T Agishi.   

Abstract

A nationwide survey was made to find out patients with malignant tumours among the dialysis population. A total of 354 malignant tumours were detected during the time of survey. Consistent with the incidence in the Japanese general population, the most frequently detected malignant tumour was gastric cancer, accounting for about one third of the total. Overall the incidence of tumour death was 2.31 times higher in males and 4.3 times higher in females. However, the high incidence of gynaecological and urinary tract tumours would suggest that some of them might be causative factors for the development of renal failure.

Entities:  

Mesh:

Year:  1981        PMID: 7329999

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  4 in total

Review 1.  Review of Helicobacter pylori infection and chronic renal failure.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Ther Apher Dial       Date:  2010-08-31       Impact factor: 1.762

2.  Cancer in patients on chronic dialysis in Korea.

Authors:  Jung Eun Lee; Seung Hyeok Han; Byoung Chul Cho; Jung Tak Park; Tae Hyun Yoo; Beom Seok Kim; Hyeong Cheon Park; Shin-Wook Kang; Ho Yung Lee; Dae-Suk Han; Sung Kyu Ha; Kyu Hun Choi
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

Review 3.  Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis.

Authors:  Mitsushige Sugimoto; Hideo Yasuda; Akira Andoh
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

4.  Death Does Matter--Cancer Risk in Patients With End-Stage Renal Disease: A Nationwide Population-Based Study With Competing Risk Analyses.

Authors:  Shih-Feng Weng; Yu-Hsien Chiu; Ren-Long Jan; Yi-Chen Chen; Chih-Chiang Chien; Jhi-Joung Wang; Chin-Chen Chu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.